Profile data is unavailable for this security.
About the company
Panbela Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is involved in enrolling patients in its randomized double-blind placebo-controlled clinical trial for the treatment of pancreatic cancer. The Company's lead assets are ivospemin (SBP-101), FlynpoviTM (eflornithine (CPP-1X) and sulindac), and eflornithine (CPP-1X). Ivospemin is a polyamine analog designed to induce polyamine metabolic inhibition (PMI). Flynpovi is a combination of CPP-1X (eflornithine) and sulindac. It has a dual mechanism of action whereby it suppresses the synthesis of new polyamines and increases the export and catabolism of polyamines from the diet and microbiome. Eflornithine is being developed as a single-agent tablet or high-dose powder sachet for several indications, including prevention of gastric cancer, treatment of neuroblastoma and recent onset Type 1 diabetes metastatic castration-resistant prostate cancer, and STK-11 mutant NSCLC.
- Revenue in USD (TTM)0.00
- Net income in USD-27.26m
- Incorporated2011
- Employees7.00
- LocationPanbela Therapeutics Inc712 Vista Blvd # 305WACONIA 55387United StatesUSA
- Phone+1 (952) 479-1196
- Websitehttps://panbela.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dermata Therapeutics Inc | 0.00 | -8.69m | 1.70m | 8.00 | -- | 6.71 | -- | -- | -24.67 | -24.67 | 0.00 | 0.5717 | 0.00 | -- | -- | 0.00 | -120.05 | -- | -146.08 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 18.90 | -- | -- | -- |
Qualigen Therapeutics Inc | 0.00 | -12.48m | 1.70m | 4.00 | -- | -- | -- | -- | -2.46 | -2.64 | 0.00 | -0.3923 | 0.00 | -- | -- | 0.00 | -118.15 | -- | -364.72 | -- | 21.30 | -- | -- | -- | -- | -7.41 | -- | -- | -- | -- | 10.22 | -- | -- | -- |
PainReform Ltd | 0.00 | -12.54m | 1.76m | 6.00 | -- | 0.7109 | -- | -- | -7.77 | -7.77 | 0.00 | 0.9988 | 0.00 | -- | -- | 0.00 | -158.88 | -55.47 | -222.89 | -68.20 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -6.28 | -- | -- | -- |
Hi-Great Group Holding Co | 109.49k | -121.76k | 1.78m | -- | -- | -- | -- | 16.26 | -0.0012 | -0.0012 | 0.0011 | -0.0011 | 0.8224 | 0.8406 | -- | -- | -91.46 | -- | -- | -- | 46.50 | -- | -111.21 | -- | 0.0144 | -52.41 | -- | -- | -47.32 | -- | -3,789.70 | -- | -- | -- |
SYBLEU Inc | 11.70k | -307.88k | 1.84m | -- | -- | -- | -- | 157.17 | -0.0293 | -0.0293 | 0.0011 | -0.0367 | 0.0641 | -- | -- | -- | -168.63 | -- | -- | -- | -- | -- | -2,631.45 | -- | -- | -8.48 | 4.96 | -- | 0.00 | -- | 26.51 | -- | -- | -- |
SOHM Inc | -100.00bn | -100.00bn | 1.84m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
CanaQuest Medical Corp | 0.00 | -808.07k | 1.92m | -- | -- | -- | -- | -- | -0.0514 | -0.0514 | 0.00 | -0.037 | 0.00 | -- | -- | -- | -1,084.38 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 57.42 | -- | -- | -- |
Panbela Therapeutics Inc | 0.00 | -27.26m | 1.94m | 7.00 | -- | -- | -- | -- | -20.38 | -20.38 | 0.00 | -0.6563 | 0.00 | -- | -- | 0.00 | -201.94 | -215.89 | -809.38 | -476.38 | -- | -- | -- | -- | -- | -161.79 | 4.16 | -- | -- | -- | 27.68 | -- | -- | -- |
Twinlab Consolidated Holdings Inc | 12.65m | -9.55m | 1.94m | 17.00 | -- | -- | -- | 0.1537 | -0.0369 | -0.0502 | 0.0488 | -0.5447 | 1.01 | 1.49 | 7.30 | 743,941.20 | -76.13 | -60.53 | -- | -- | 34.59 | 21.36 | -75.51 | -37.72 | 0.0094 | -0.0108 | -- | -- | -20.87 | -28.58 | -20.28 | -- | -- | -- |
VG Life Sciences Inc | 0.00 | -4.30m | 2.11m | 7.00 | -- | -- | -- | -- | -0.0721 | -0.0721 | 0.00 | -0.0491 | 0.00 | -- | -- | -- | -384.41 | -294.08 | -- | -- | -- | -- | -- | -587,591.90 | -- | -1.70 | -- | -- | -- | -- | 16.58 | -- | -- | -- |
America Great Health | 219.13k | -859.20k | 2.11m | 7.00 | -- | -- | -- | 9.64 | -0.00004 | -0.00004 | 0.00001 | -0.0002 | 0.6746 | 0.0721 | 18.16 | 31,304.29 | -265.62 | -543.96 | -- | -- | 95.92 | -247.36 | -393.74 | -1,193.55 | 0.035 | -1.37 | -- | -- | 95.23 | -- | 84.35 | -- | -- | -- |
Windtree Therapeutics Inc | 0.00 | -5.96m | 2.11m | 15.00 | 0.1927 | 0.1181 | -- | -- | 18.53 | 18.53 | 0.00 | 30.23 | 0.00 | -- | -- | 0.00 | -18.26 | -44.51 | -20.72 | -48.38 | -- | -- | -- | -94,533.34 | -- | -- | 0.00 | -- | -- | -- | 48.25 | -- | -- | -- |
Link Reservations Inc | 0.00 | -480.90k | 2.11m | 0.00 | -- | -- | -- | -- | -46.51 | -46.51 | 0.00 | -13.99 | 0.00 | -- | -- | -- | -246.84 | -- | -- | -- | -- | -- | -- | -- | -- | -2.43 | -- | -- | -- | -- | -22.69 | -- | -- | -- |
CYANOTECH CORP | 22.49m | -4.62m | 2.12m | 86.00 | -- | 0.1518 | -- | 0.0941 | -0.7265 | -0.7265 | 3.53 | 2.01 | 0.7889 | 1.53 | 10.73 | 261,546.50 | -16.19 | -2.32 | -21.07 | -2.96 | 29.59 | 35.88 | -20.52 | -2.33 | 0.3702 | -5.93 | 0.3299 | -- | -35.56 | -7.44 | -259.70 | -- | 1.22 | -- |
American Green Inc | -100.00bn | -100.00bn | 2.14m | 6.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
Woodbury Financial Services, Inc.as of 31 Dec 2023 | 4.00 | 0.00% |
Tower Research Capital LLCas of 31 Mar 2024 | 0.00 | 0.00% |
Citadel Securities LLCas of 31 Mar 2024 | 0.00 | 0.00% |
Geode Capital Management LLCas of 31 Mar 2024 | 0.00 | 0.00% |
Two Sigma Securities LLCas of 31 Mar 2024 | 0.00 | 0.00% |
HRT Financial LLCas of 31 Mar 2024 | 0.00 | 0.00% |